Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclin E in human cancers.

R Donnellan1, R Chetty

  • 1Department of Pathology, University of Natal Medical School, Durban, South Africa. donnellanr@med.und.ac.za

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|May 4, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.

Scientific reports·2018
Same author

Pulmonary veno-occlusive disease associated with hypertrophic cardiomyopathy.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

The Ueno method for substaging pT1 colorectal adenocarcinoma by depth and width measurement: an interobserver study.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2015
Same author

Gastrointestinal pathology: recent developments and concepts.

Journal of clinical pathology·2014
Same author

Impact of the consideration of serrated polyps to the interval of colonoscopic surveillance in the NHS Bowel Cancer Screening Programme.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2014
Same author

Plasma-cell rich lymphangiosarcoma: an under-recognized variant and potential diagnostic pitfall.

The British journal of dermatology·2011
Same journal

Vancomycin Protects Against Lung Injury and Promotes Butyrate Metabolism.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Raptor and Drp1 Function Synthetically to Control Hypoxic Death and the Mitochondrial Network in Caenorhabditis elegans.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

SENP3 Deficiency Inhibits Atherosclerosis by Regulating TLR4/NF-κB and SOAT2.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

A Novel lncRNA-ADAT1/miR-449a-5p/FZD5 Axis Regulates Melanogenesis and Proliferation in Goat Melanocytes.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

FMRP-Mediated Proteasome Regulation: A Novel Mechanism in ALS Pathology.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Irisin Pretreatment Reveals Enhanced Protective Response Upon Hematopoietic Reconstitution in the Acquired Aplastic Anemia Mouse Model.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
See all related articles

Cell cycle regulators like cyclin E are crucial in cancer development. Understanding how cyclin E interacts with other molecules could lead to new cancer treatments.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Cell cycle regulators, such as cyclin E, are implicated in neoplasia.
  • Cyclin E forms a complex with a protein kinase, initiating DNA synthesis.
  • Cyclin-dependent kinase inhibitors (CKIs) regulate cyclin E activity.

Purpose of the Study:

  • To elucidate the mechanisms of neoplasia by studying cyclin E interactions.
  • To explore the prognostic value of cyclin E in common cancers.
  • To investigate cyclin E as a potential therapeutic target for cancer treatment.

Main Methods:

  • Analysis of cyclin E protein interactions.
  • Investigation of the role of cyclin-dependent kinase inhibitors (CKIs).
  • Examination of oncogenic viral proteins' effects on cyclin E pathways.

Related Experiment Videos

Main Results:

  • Interactions involving cyclin E and CKIs are key to understanding cancer mechanisms.
  • These interactions may offer prognostic insights for various cancers.
  • Cyclin E's role in cell cycle regulation is central to neoplasia.

Conclusions:

  • Cyclin E and its regulatory pathways are vital in cancer.
  • Understanding these molecular interactions can improve cancer prognosis.
  • Targeting cyclin E presents a promising future strategy for cancer therapy.